Comparison of treatment costs of grade 3/4 adverse events associated with erlotinib or pemetrexed maintenance therapy for patients with advanced non-small-cell lung cancer (NSCLC) in Germany, France, Italy, and Spain.
| Image |  |
|---|---|
| Description | scientific article published on 17 May 2011 |
| Author/s |
author: Helge G Bischoff Stefan Walzer Javier de Castro Carpeño Christos Chouaid Filippo de Marinis Alain Vergnenegre Francesco Grossi |
| Publication date | May 17, 2011 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |